<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a patient with Philadelphia chromosome (Ph1)-positive <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) who developed it 2.5 years after being diagnosed with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The patient initially had refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), but progressed to refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) 2 years later, that terminated in ALL </plain></SENT>
<SENT sid="2" pm="."><plain>An immunophenotypic analysis of the lymphoblasts revealed CD10 and CD19 positive cells </plain></SENT>
<SENT sid="3" pm="."><plain>The karyotype was <z:mpath ids='MPATH_458'>normal</z:mpath> 46,XY in RA phase, 46,XY,20q-during the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> phase, and 46,XY,t(9;22)(q34;q11),20q-during the ALL phase </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, p190 BCR-ABL <z:chebi fb="2" ids="33699">mRNA</z:chebi> was detected in the ALL blasts </plain></SENT>
<SENT sid="5" pm="."><plain>These findings indicate that this ALL arose from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> clone through multiple cytogenetic evolutions, the final event of which was the acquisition of p190 BCR-ABL type Ph1 </plain></SENT>
</text></document>